HAEMONETICS CORPHAEMONETICS CORPHAEMONETICS CORP

HAEMONETICS CORP

No trades
See on Supercharts

Price target

103.380.000.00%
The 10 analysts offering 1 year price forecasts for HAZ have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to HAZ in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HAZ EPS for the last quarter is 1.01 EUR despite the estimation of 0.96 EUR. In the next quarter EPS is expected to reach 1.12 EUR. Track more of HAEMONETICS CORP financials and stay on top of what is up with the company.
In the next quarter HAEMONETICS CORP revenue is expected to reach ‪336.10 M‬ EUR. Check out HAEMONETICS CORP revenue and earnings and make informed decisions.
According to analysts, HAZ price target is 103.38 EUR with a max estimate of 116.62 EUR and a min estimate of 79.30 EUR. Check if this forecast comes true in a year, meanwhile watch HAEMONETICS CORP stock price chart and keep track of the current situation with HAZ news and stock market news.
We've gathered opinions of 11 analysts rating HAZ stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.